1,25(OH) 2 D 3 has antitumour effects in CRC by acting on tumour stromal fibroblasts and, thus, the therapeutic action of VDR agonists may extend to patients with CRC who express VDR in tumour stromal fibroblasts even in the absence of VDR expression in carcinoma cells. 1,25(OH) 2 D 3 action is mediated by the vitamin D receptor (VDR), a member of the superfamily of nuclear receptors that upon ligand activation regulates the transcription rate of hundreds of human genes.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Gemma
Contact Gemma, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack